Neuhyll Aus Pty Ltd

This early-stage trial is testing the safety and tolerability of a new drug called NHL907 in 64 healthy adults aged 18 to 60. Participants receive multiple oral doses of NHL907 or a placebo. The study measures side effects and how the drug moves through the body, but does not aim…